- Home
- PLYM vs CSTL Comparison
PLYM vs CSTL Comparison
Compare PLYM & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLYM
- CSTL
- Stock Information
- Founded
- PLYM 2011
- CSTL 2007
- Country
- PLYM United States
- CSTL United States
- Employees
- PLYM 43
- CSTL N/A
- Industry
- PLYM Real Estate Investment Trusts
- CSTL Medical Specialities
- Sector
- PLYM Real Estate
- CSTL Health Care
- Exchange
- PLYM Nasdaq
- CSTL Nasdaq
- Market Cap
- PLYM 817.0M
- CSTL 848.1M
- IPO Year
- PLYM 2017
- CSTL 2019
- Fundamental
- Price
- PLYM $18.01
- CSTL $27.53
- Analyst Decision
- PLYM Buy
- CSTL Strong Buy
- Analyst Count
- PLYM 8
- CSTL 6
- Target Price
- PLYM $24.50
- CSTL $39.67
- AVG Volume (30 Days)
- PLYM 373.3K
- CSTL 314.0K
- Earning Date
- PLYM 02-19-2025
- CSTL 11-04-2024
- Dividend Yield
- PLYM 5.33%
- CSTL N/A
- EPS Growth
- PLYM N/A
- CSTL N/A
- EPS
- PLYM 0.01
- CSTL 0.21
- Revenue
- PLYM $201,569,000.00
- CSTL $311,878,000.00
- Revenue This Year
- PLYM N/A
- CSTL $51.36
- Revenue Next Year
- PLYM $6.60
- CSTL N/A
- P/E Ratio
- PLYM $976.16
- CSTL $130.87
- Revenue Growth
- PLYM 2.64
- CSTL 62.43
- 52 Week Low
- PLYM $17.22
- CSTL $16.97
- 52 Week High
- PLYM $24.71
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- PLYM 39.07
- CSTL 38.11
- Support Level
- PLYM $18.49
- CSTL $26.30
- Resistance Level
- PLYM $19.21
- CSTL $32.57
- Average True Range (ATR)
- PLYM 0.53
- CSTL 1.63
- MACD
- PLYM -0.02
- CSTL -0.32
- Stochastic Oscillator
- PLYM 37.28
- CSTL 19.52
About PLYM Plymouth Industrial REIT Inc.
Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income primarily from the rental revenue through its properties.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.